Page last updated: 2024-08-26

diosgenin and Thrombosis

diosgenin has been researched along with Thrombosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, W; Ji, C; Niu, H; Wei, Z; Wen, L; Xia, Q; Xin, G; Zheng, H	1
Gu, J; Huang, W; Ji, C; Ma, L; Niu, H; Qin, C; Wang, H; Wei, Z; Xin, G; Xing, Z; Zheng, H	1

Other Studies

2 other study(ies) available for diosgenin and Thrombosis

Article	Year
Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo. Bioorganic & medicinal chemistry letters, 2016, 07-15, Volume: 26, Issue:14 Topics: Administration, Oral; Animals; Diosgenin; Disease Models, Animal; Dose-Response Relationship, Drug; Mice; Molecular Structure; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Structure-Activity Relationship; Thrombosis	2016
The diosgenin prodrug nanoparticles with pH-responsive as a drug delivery system uniquely prevents thrombosis without increased bleeding risk. Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:3 Topics: Animals; Diosgenin; Drug Delivery Systems; Fibrinolytic Agents; Hemorrhage; Hepatocytes; Humans; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Micelles; Nanoparticles; Platelet Aggregation Inhibitors; Prodrugs; Rats; Rats, Sprague-Dawley; Risk Factors; Thrombosis	2018

Article

Year

Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo.

Bioorganic & medicinal chemistry letters, 2016, 07-15, Volume: 26, Issue:14

Topics: Administration, Oral; Animals; Diosgenin; Disease Models, Animal; Dose-Response Relationship, Drug; Mice; Molecular Structure; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Structure-Activity Relationship; Thrombosis

2016

The diosgenin prodrug nanoparticles with pH-responsive as a drug delivery system uniquely prevents thrombosis without increased bleeding risk.

Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:3

Topics: Animals; Diosgenin; Drug Delivery Systems; Fibrinolytic Agents; Hemorrhage; Hepatocytes; Humans; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Micelles; Nanoparticles; Platelet Aggregation Inhibitors; Prodrugs; Rats; Rats, Sprague-Dawley; Risk Factors; Thrombosis

2018